Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Transfusion reaction
ADR ID BADD_A04370
ADR Hierarchy
01      Blood and lymphatic system disorders
01.05      Haematological disorders NEC
01.05.01      Haematological disorders
01.05.01.005      Transfusion reaction
10      Immune system disorders
10.02      Immune disorders NEC
10.02.04      Blood isoimmune reactions
10.02.04.001      Transfusion reaction
12      Injury, poisoning and procedural complications
12.02      Procedural related injuries and complications NEC
12.02.08      Transfusion related complications
12.02.08.001      Transfusion reaction
Description Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility. | Transfusion reaction complications such as delayed suppression of ERYTHROPOIESIS may occur after destruction of autologous RED BLOOD CELLS in Hemolytic Transfusion Reaction. [MeSH]
MedDRA Code 10044359
MeSH ID D065227
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Other transfusion reaction, not elsewhere classified | Transfusion reaction | Transfusion Reaction | Transfusion Reactions | Blood Transfusion-Associated Adverse Reactions | Blood Transfusion Associated Adverse Reactions | Delayed Hemolytic Transfusion Reaction | Acute Hemolytic Transfusion Reaction | Febrile Non-Hemolytic Transfusion Reaction | Febrile Non Hemolytic Transfusion Reaction | Hypotensive Transfusion Reaction | Reaction, Hypotensive Transfusion | Transfusion Reaction, Hypotensive | Transfusion Reactions, Hypotensive | Delayed Serologic Transfusion Reaction | Transfusion-Associated Allergic Reaction | Allergic Reaction, Transfusion-Associated | Transfusion Associated Allergic Reaction | Transfusion-Associated Circulatory Overload | Circulatory Overload, Transfusion-Associated | Circulatory Overloads, Transfusion-Associated | Transfusion Associated Circulatory Overload | Transfusion-Associated Circulatory Overloads | Transfusion-Associated Graft Vs. Host Disease | Transfusion Associated Graft Vs. Host Disease | TAGHD | Transfusion-Associated Dyspnea | Dyspnea, Transfusion-Associated | Transfusion Associated Dyspnea | Transfusion-Transmitted Infection | Infection, Transfusion-Transmitted | Transfusion Transmitted Infection | Transfusion-Transmitted Infections | Hemolytic Transfusion Reaction | Hemolytic Transfusion Reactions | Reaction, Hemolytic Transfusion | Reactions, Hemolytic Transfusion | Transfusion Reaction, Hemolytic | Transfusion Reactions, Hemolytic | Post-Transfusion Purpura | Post Transfusion Purpura | Purpura, Post-Transfusion | Posttransfusion Purpura | Posttransfusion Purpuras | Purpura, Posttransfusion
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00064Alemtuzumab--
BADD_D00132Amphotericin b--
BADD_D00194Azacitidine--
BADD_D00284Bortezomib--
BADD_D00364Carboplatin--
BADD_D00593Decitabine--
BADD_D00897Filgrastim--
BADD_D01253Lenalidomide--
BADD_D01609Omacetaxine mepesuccinate--
The 1th Page    1    Total 1 Pages